Cipla Ltd. on Tuesday announced final dividend of Rs 16 per equity share, with a face value Rs 2 each for the financial year ending March 2025. The dividend, upon approval by the shareholders, will be paid to shareholders within 30 days from the date of the Annual General Meeting.
The company's board of directors recommended a final dividend of Rs 13 per equity share for the financial year ended March 31, 2025 and a special dividend of Rs 3 per equity share on the occasion of completing 90 years of the company, taking the total dividend to Rs 16 per equity share, as per filing.
The board has fixed June 27 as the record date for the purpose of payment of final dividend, as per an exchange filing.
Cipla Ltd.'s consolidated net profit rose 30% year-on-year in the fourth quarter of the current financial year, beating analysts' estimates. The drugmaker posted a consolidated bottom line of Rs 1,222 crore in the quarter-ended March, according to an exchange filing on Tuesday. That compares with the Rs 1,023-crore consensus estimate of analysts tracked by Bloomberg.
The company's revenue climbed 9% year-on-year to Rs 6,729.69 crore, whereas the earnings before interest, taxes, depreciation and amortisation increased by 17% to Rs 1,538 crore.
Shares of Cipla were trading 0.69% higher at Rs 1,521.80 apiece, compared to 1.3% decline at the benchmark NSE Nifty 50 as of 2:00 p.m. It has risen 7.28% in the last 12 months and fallen 0.69% on a year-to-date basis. The total traded volume so far in the day stood at 1.56 times its 30-day average. The relative strength index was at 50.10.
Twenty-four out of 37 analysts tracking the company have a 'buy' rating on the stock, eight recommend a 'hold' and five suggest a 'sell', according to Bloomberg data. The average of 12-month analysts' price target implies a potential upside of 9.5%.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
